BATTLE Trial: Bare Metal Stent Versus Paclitaxel Eluting Stent in the Setting of Primary Stenting of Intermediate Length Femoropopliteal Lesions
A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 186 participants.
Also called NCT02004951
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose health services research
- Phase
- Not applicable
- Enrolled
- 186 participants
- Sponsor
- Registry
-
NCT02004951
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- France
- Registry status
- Terminated
Technical summary
Registry record NCT02004951. Randomized; no masking; primary purpose health services research. Start 2014-03-25 (actual); primary completion 2017-08-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- BATTLE Trial: Bare Metal Stent Versus Paclitaxel Eluting Stent in the Setting of Primary Stenting of Intermediate Length Femoropopliteal Lesions
- Acronym
- BATTLE
- Condition
- Peripheral Arterial Disease
- Condition
- Femoropopliteal Lesions
- Intervention (Device)
- Misago RX
- Intervention (Device)
- Zilver PTX
- Lead sponsor
- Nantes University Hospital
Record details
- Record id
cardio:ct-nct02004951- Content hash
46d1a3c68966b06f275f1996d5b4aeddac66b6b127fd9005faabfdd576d9fde6